UBS Analyst Negative on Evercore and Moelis & Company - Downgrades to Sell
Investing.com
Published Sep 23, 2022 01:07PM ET
UBS Analyst Negative on Evercore (EVR) and Moelis & Company (MC) - Downgrades to Sell
By Sam Boughedda
In separate notes Friday, a UBS analyst downgraded shares of Evercore Partners Inc (NYSE:EVR) and Moelis & Company (NYSE:MC) to Sell.
The analyst lowered the price target of Evercore to $85 from $99 and Moelis & Company to $35 from $43.
In the Evercore note, the analyst explained that M&A sluggishness weighs on the company's pipeline while "belt tightening brings unfamiliar terrain."
"We are downgrading EVR from Neutral to Sell as their shrinking deal pipeline increases the risk of inflexibility in their expense. Based on our analysis, consensus is not capturing the impact of fixed comp expense, with consensus comp ratios for EVR in 2H22 of 61% compared to our estimates of 63%. Negative operating leverage is likely to persist given that EVR's public revenue pipeline is down 40% Y/Y, compared to a 29% average decline across the boutiques," the analyst wrote.
He added: "Despite strategic investments in diversifying their business model away from core M&A, EVR's revenue profile is still heavily weighted towards advisory fees (80% of total revenue), and it is hard to have confidence in other revenue streams given limited visibility."
Meanwhile, the analyst stated that Moelis & Company is between a rock and a hard place, with weak earnings potentially limiting capital return and risk dilution.
"We are downgrading MC from Neutral to Sell, as the degree of fixed compensation expense (i.e., deferred comp + salaries) is likely to add considerable upward pressure to the company's adjusted comp ratio (our forecasts call for 2H22 ratio of 65% vs 59% in 1H22)," explained the analyst. "Moreover, MC's revenue picture continues to deteriorate as the public revenue pipeline is down >50% Y/Y, and the pace of replenishment remains sluggish."
Evercore and Moelis shares are down over 6% at the time of writing.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.